High-dose methylprednisolone is effective in the management of acute graft-versus-host disease in severe combined immune deficiency

J Allergy Clin Immunol. 2008 Dec;122(6):1215-6. doi: 10.1016/j.jaci.2008.06.023. Epub 2008 Jul 30.

Authors

Raz Somech, Fotini D Kavadas, Adelle Atkinson, Eyal Grunebaum, Chaim M Roifman

PMID: 18672279
DOI: 10.1016/j.jaci.2008.06.023

No abstract available

Publication types

Letter

MeSH terms

Acute Disease
Anti-Inflammatory Agents / administration & dosage*
Bone Marrow Transplantation*
Disease-Free Survival
Female
Graft vs Host Disease / drug therapy*
Graft vs Host Disease / genetics
Graft vs Host Disease / mortality
Humans
Infant
Infant, Newborn
Male
Methylprednisolone / administration & dosage*
Retrospective Studies
Severe Combined Immunodeficiency / genetics
Severe Combined Immunodeficiency / mortality
Severe Combined Immunodeficiency / therapy*

Substances

Anti-Inflammatory Agents
Methylprednisolone